PDB46 COST-UTILITY OF INSULIN DETEMIR VERSUS NPH FOR TYPE I DIABETES PATIENTS TREATED WITH BASAL-BOLUS THERAPY IN A FRENCH SETTING, A MODELING EVALUATION BASED ON RESULTS FROM A META-ANALYSIS OF THREE CLINICAL TRIALS
Nov 1, 2007, 00:00
10.1016/S1098-3015(10)64994-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)64994-7/fulltext
Title :
PDB46 COST-UTILITY OF INSULIN DETEMIR VERSUS NPH FOR TYPE I DIABETES PATIENTS TREATED WITH BASAL-BOLUS THERAPY IN A FRENCH SETTING, A MODELING EVALUATION BASED ON RESULTS FROM A META-ANALYSIS OF THREE CLINICAL TRIALS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64994-7&doi=10.1016/S1098-3015(10)64994-7
First page :
Section Title :
Open access? :
No
Section Order :
153